文献速递眼底病与葡萄膜炎白内障与屈光手术

23G玻璃体切除术治疗白内障术后晶状体碎片残留的当代结局与预后因素

Contemporary Outcomes and Prognostic Factors of 23-Gauge Vitrectomy for Retained Lens Fragments After Phacoemulsification.
PubMed 文献 · Am J Ophthalmol · 2020-05-29

该回顾性介入病例系列纳入2012至2017年291眼白内障术后晶状体碎片残留行23G微创玻璃体切除术者。术后6个月62.9%达BCVA优于20/40,15.5%差于20/200;最终视力仅与术前白内障术前视力、年龄<75岁、无糖尿病黄斑水肿或持续性黄斑囊样水肿独立相关。

要点

  • 23G玻璃体切除术后6个月62.9%术眼BCVA优于20/40,15.5%差于20/200。
  • 最终视力优于20/40仅与术前较好视力、年龄<75岁、无DME或持续性CME独立相关。
  • 延迟玻璃体切除超过2周、最终无晶状体状态及术前较差视力预测视力差于20/200。

核心结论

  • 23G玻璃体切除术治疗晶状体碎片残留的视力结局与既往以非微创手术为主的队列相当,但未达无并发症白内障手术的基准。
  • 人工晶状体类型或植入时机不影响最终视力。

研究设计与样本

  • 回顾性、介入性病例系列,纳入2012至2017年291例连续患者(291眼),均因白内障术后晶状体碎片残留行23G微创玻璃体切除术。
  • 分析白内障术前及玻璃体切除术中参数、术后并发症及最佳矫正视力,采用单因素和多因素logistic回归分析6个月时视力优于20/40或差于20/200的相关因素。

主要发现

  • LogMAR BCVA从白内障术前0.73±0.70改善至玻璃体切除术后0.46±0.63(P<.001),玻璃体切除术前为1.43±0.79。
  • 术后6个月183眼(62.9%)BCVA优于20/40,45眼(15.5%)差于20/200。
  • 最常见并发症为新发高眼压29眼(10%)和暂时性黄斑囊样水肿25眼(8.6%),玻璃体切除术后视网膜脱离9眼(3.1%)。

关键数值与推荐

  • 最终BCVA优于20/40仅独立关联于较好的白内障术前视力、年龄<75岁、无既存糖尿病黄斑水肿或玻璃体切除术后持续性黄斑囊样水肿(P<.05)。
  • 仅较差的术前视力、延迟玻璃体切除至2周以后及最终无晶状体状态独立预测BCVA差于20/200(P<.05)。

临床怎么用

  • 对白内障术后晶状体碎片残留者,23G玻璃体切除术可改善视力,但应告知视力结局可能低于无并发症白内障手术基准。
  • 术前较差视力、高龄、既存DME或术后持续性CME提示视力预后较差,需加强围手术期管理。
  • 避免将玻璃体切除延迟至2周以后可能有助于降低视力差于20/200的风险。

局限性

  • 回顾性设计,可能存在选择偏倚和未测量混杂。
  • 单中心连续病例系列,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To provide data on visual acuity (VA) outcomes and prognostic factors of microincision (23-gauge) vitrectomy surgery (MIVS) for retained lens fragments after complicated cataract surgery. DESIGN: Retrospective, interventional case series from 2012 to 2017. METHODS: Precataract surgery and intraoperative (vitrectomy) parameters, postvitrectomy complications, and best-corrected visual acuities (BCVAs) were identified. Vitrectomy was performed as early as corneal clarity permitted. Univariate and multivariate logistic regression were used to characterize factors associated with achieving VA better than 20/40, or worse than 20/200 at 6 months. RESULTS: This study included 291 consecutive eyes (291 patients). LogMAR BCVA improved from 0.73 ± 0.70 before cataract surgery to 0.46 ± 0.63 (P < .001) after vitrectomy. The previtrectomy VA was 1.43 ± 0.79. At 6 months, 183 (62.9%) and 45 patients (15.5%) achieved BCVAs better than 20/40 and worse than 20/200, respectively. Most frequent complications were de novo ocular hypertension (29 eyes, 10%) and transient cystoid macular edema (25 eyes, 8.6%). Postvitrectomy retinal detachment occurred in 9 eyes (3.1%). Final VA of 20/40 or better was independently associated only with better precataract surgery VA, age <75 years, absence of preexisting diabetic macular edema (DME) or postvitrectomy persistent cystoid macular edema (P < .05). Only poorer precataract surgery VA, delaying vitrectomy to later than 2 weeks, and final aphakic status were independently predictive of 20/200 or worse VA (P < .05). CONCLUSION: Contemporary VA outcomes of 23-gauge vitrectomy for retained lens fragments are comparable with that of prior predominantly non-MIVS cohorts, but fall short of benchmarks for uncomplicated cataract surgery. IOL type or timing of placement do not impact final VA.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Chan EW, Yang E, Eldeeb M, et al. Contemporary Outcomes and Prognostic Factors of 23-Gauge Vitrectomy for Retained Lens Fragments After Phacoemulsification. Am J Ophthalmol. 2020. PMID: 32479808. doi:10.1016/j.ajo.2020.05.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。